Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Neutral

Price to Earnings Rating

Strong Sell

Analyst Rating

Strong Sell

Simple Moving Average

Strong Sell

Exponential Moving Average

Strong Sell

Relative Strength Index

Sell

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Sell

C

RxSight, Inc. Common Stock (RXST)

Ophthalmic Goods

https://www.rxsight.com

RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery.

100 COLUMBIA STREET, SUITE 120
ALISO VIEJO, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

07/30/2021

Market Cap

2,059,140,492

Shares Outstanding

35,860,000

Weighted SO

35,861,604

Total Employees

N/A

Upcoming Earnings

08/05/2024

Similar Tickers

AXGN --.--%

TMCI --.--%

LUNG --.--%

OFIX --.--%

KIDS --.--%

SGHT --.--%

FNA --.--%

SSKN --.--%

NPCE --.--%

Beta

1.1880

Last Div

0.0000

Range

20.66-66.54

Chg

1.1500

Avg Vol

565180

Mkt Cap

2059140492

Exch

NASDAQ

Country

US

Phone

949 521 7830

DCF Diff

N/A

DCF

0.0000

Div Yield

0.0000

P/S

16.6535

EV Multiple

-54.2187

P/FV

7.2508

Div Yield %

0.0000

P/E

-54.2678

PEG

-1.3079

Payout

0.0000

Current Ratio

14.3349

Quick Ratio

13.3439

Cash Ratio

1.2460

DSO

75.9337

DIO

149.9534

Op Cycle

225.8871

DPO

39.2950

CCC

186.5921

Gross Margin

0.6172

Op Margin

-0.3426

Pretax Margin

-0.2972

Net Margin

-0.2974

Eff Tax Rate

-0.0005

ROA

-0.1204

ROE

-0.1933

ROCE

-0.1482

NI/EBT

1.0005

EBT/EBIT

0.8675

EBIT/Rev

-0.3426

Debt Ratio

0.0373

D/E

0.0415

LT Debt/Cap

0.0373

Total Debt/Cap

0.0398

Int Coverage

187.4646

CF/Debt

-2.7421

Equity Multi

1.1101

Rec Turnover

4.8068

Pay Turnover

9.2887

Inv Turnover

2.4341

FA Turnover

5.3154

Asset Turnover

0.4047

OCF/Share

-0.8136

FCF/Share

-0.9627

Cash/Share

6.0663

OCF/Sales

-0.2530

FCF/OCF

1.1833

CF Coverage

-2.7421

ST Coverage

-42.5095

CapEx Coverage

-5.4564

Div&CapEx Cov

-5.4564

P/BV

7.2508

P/B

7.2508

P/S

16.6535

P/E

-54.2678

P/FCF

-55.6209

P/OCF

-63.7798

P/CF

-63.7798

PEG

-1.3079

P/S

16.6535

EV Multiple

-54.2187

P/FV

7.2508

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Jan 07, 10:00 RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2023 Financial and Operational Results and 2024 Guidance GlobeNewswire Inc. Jan 07, 10:00 RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2023 Financial and Operational Results and 2024 Guidance GlobeNewswire Inc. Jan 07, 10:00 RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2023 Financial and Operational Results and 2024 Guidance GlobeNewswire Inc. Jan 07, 10:00 RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2023 Financial and Operational Results and 2024 Guidance GlobeNewswire Inc. Jan 07, 10:00 RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2023 Financial and Operational Results and 2024 Guidance GlobeNewswire Inc. Jan 07, 10:00 RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2023 Financial and Operational Results and 2024 Guidance GlobeNewswire Inc. Jan 07, 10:00 RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2023 Financial and Operational Results and 2024 Guidance GlobeNewswire Inc. Dec 27, 16:05 RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference GlobeNewswire Inc. Dec 27, 16:05 RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference Benzinga Dec 13, 09:00 Analyst Expectations for RxSight's Future

Revenue Product Segmentation